Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis

Rheumatoid arthritis (RA) is a chronic multisystem disease, therapy of which remains a challenge for basic research. The present work examined the effect of unconjugated bilirubin (UCB) administration in adjuvant-induced arthritis (AIA)—an experimental model, in which oxidative stress (OS), inflamma...

Full description

Bibliographic Details
Main Authors: Tomas Sykora, Pavel Babal, Kristina Mikus-Kuracinova, Frantisek Drafi, Silvester Ponist, Monika Dvorakova, Pavol Janega, Katarina Bauerova
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/16/8662
_version_ 1797523556168368128
author Tomas Sykora
Pavel Babal
Kristina Mikus-Kuracinova
Frantisek Drafi
Silvester Ponist
Monika Dvorakova
Pavol Janega
Katarina Bauerova
author_facet Tomas Sykora
Pavel Babal
Kristina Mikus-Kuracinova
Frantisek Drafi
Silvester Ponist
Monika Dvorakova
Pavol Janega
Katarina Bauerova
author_sort Tomas Sykora
collection DOAJ
description Rheumatoid arthritis (RA) is a chronic multisystem disease, therapy of which remains a challenge for basic research. The present work examined the effect of unconjugated bilirubin (UCB) administration in adjuvant-induced arthritis (AIA)—an experimental model, in which oxidative stress (OS), inflammation and inadequate immune response are often similar to RA. Male Lewis rats were randomized into groups: CO—control, AIA—untreated adjuvant-induced arthritis, AIA-BIL—adjuvant-induced arthritis administrated UCB, CO-BIL—control with administrated UCB. UCB was administered <i>intraperitoneally</i> 200 mg/kg of body weight daily from 14th day of the experiment, when clinical signs of the disease are fully manifested, to 28th day, the end of the experiment. AIA was induced by a single intradermal immunization at the base of the tail with suspension of <i>Mycobacterium butyricum</i> in incomplete Freund’s adjuvant. Clinical, hematologic, biochemical and histologic examinations were performed. UCB administration to animals with AIA lead to a significant decrease in hind paws volume, plasma levels of C-reactive protein (CRP) and ceruloplasmin, drop of leukocytes, lymphocytes, erythrocytes, hemoglobin and an increase in platelet count. UCB administration caused significantly lowered oxidative damage to DNA in arthritic animals, whereas in healthy controls it induced considerable oxidative damage to DNA. UCB administration also induced atrophy of the spleen and thymus in AIA and CO animals comparing to untreated animals. Histological signs of joint damage assessed by neutrophils infiltration and deposition of fibrin were significantly reduced by UCB administration. The effects of exogenously administered UCB to the animals with adjuvant-induced arthritis might be identified as therapeutic, in contrast to the effects of UCB administration in healthy animals rather classified as toxic.
first_indexed 2024-03-10T08:44:38Z
format Article
id doaj.art-39958f5c803c40e28fcebb86614a2eba
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T08:44:38Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-39958f5c803c40e28fcebb86614a2eba2023-11-22T07:58:34ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-08-012216866210.3390/ijms22168662Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune ArthritisTomas Sykora0Pavel Babal1Kristina Mikus-Kuracinova2Frantisek Drafi3Silvester Ponist4Monika Dvorakova5Pavol Janega6Katarina Bauerova7Department of Pathology, Faculty of Medicine, Comenius University in Bratislava, Spitalska 24, 81372 Bratislava, SlovakiaDepartment of Pathology, Faculty of Medicine, Comenius University in Bratislava, Spitalska 24, 81372 Bratislava, SlovakiaDepartment of Pathology, Faculty of Medicine, Comenius University in Bratislava, Spitalska 24, 81372 Bratislava, SlovakiaCentre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská Cesta 9, 84104 Bratislava, SlovakiaCentre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská Cesta 9, 84104 Bratislava, SlovakiaDepartment of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University in Bratislava, Spitalska 24, 81372 Bratislava, SlovakiaDepartment of Pathology, Faculty of Medicine, Comenius University in Bratislava, Spitalska 24, 81372 Bratislava, SlovakiaCentre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská Cesta 9, 84104 Bratislava, SlovakiaRheumatoid arthritis (RA) is a chronic multisystem disease, therapy of which remains a challenge for basic research. The present work examined the effect of unconjugated bilirubin (UCB) administration in adjuvant-induced arthritis (AIA)—an experimental model, in which oxidative stress (OS), inflammation and inadequate immune response are often similar to RA. Male Lewis rats were randomized into groups: CO—control, AIA—untreated adjuvant-induced arthritis, AIA-BIL—adjuvant-induced arthritis administrated UCB, CO-BIL—control with administrated UCB. UCB was administered <i>intraperitoneally</i> 200 mg/kg of body weight daily from 14th day of the experiment, when clinical signs of the disease are fully manifested, to 28th day, the end of the experiment. AIA was induced by a single intradermal immunization at the base of the tail with suspension of <i>Mycobacterium butyricum</i> in incomplete Freund’s adjuvant. Clinical, hematologic, biochemical and histologic examinations were performed. UCB administration to animals with AIA lead to a significant decrease in hind paws volume, plasma levels of C-reactive protein (CRP) and ceruloplasmin, drop of leukocytes, lymphocytes, erythrocytes, hemoglobin and an increase in platelet count. UCB administration caused significantly lowered oxidative damage to DNA in arthritic animals, whereas in healthy controls it induced considerable oxidative damage to DNA. UCB administration also induced atrophy of the spleen and thymus in AIA and CO animals comparing to untreated animals. Histological signs of joint damage assessed by neutrophils infiltration and deposition of fibrin were significantly reduced by UCB administration. The effects of exogenously administered UCB to the animals with adjuvant-induced arthritis might be identified as therapeutic, in contrast to the effects of UCB administration in healthy animals rather classified as toxic.https://www.mdpi.com/1422-0067/22/16/8662adjuvant-induced arthritisbilirubinimmunomodulationinflammationwhite blood cells
spellingShingle Tomas Sykora
Pavel Babal
Kristina Mikus-Kuracinova
Frantisek Drafi
Silvester Ponist
Monika Dvorakova
Pavol Janega
Katarina Bauerova
Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis
International Journal of Molecular Sciences
adjuvant-induced arthritis
bilirubin
immunomodulation
inflammation
white blood cells
title Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis
title_full Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis
title_fullStr Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis
title_full_unstemmed Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis
title_short Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis
title_sort hyperbilirubinemia maintained by chronic supplementation of unconjugated bilirubin improves the clinical course of experimental autoimmune arthritis
topic adjuvant-induced arthritis
bilirubin
immunomodulation
inflammation
white blood cells
url https://www.mdpi.com/1422-0067/22/16/8662
work_keys_str_mv AT tomassykora hyperbilirubinemiamaintainedbychronicsupplementationofunconjugatedbilirubinimprovestheclinicalcourseofexperimentalautoimmunearthritis
AT pavelbabal hyperbilirubinemiamaintainedbychronicsupplementationofunconjugatedbilirubinimprovestheclinicalcourseofexperimentalautoimmunearthritis
AT kristinamikuskuracinova hyperbilirubinemiamaintainedbychronicsupplementationofunconjugatedbilirubinimprovestheclinicalcourseofexperimentalautoimmunearthritis
AT frantisekdrafi hyperbilirubinemiamaintainedbychronicsupplementationofunconjugatedbilirubinimprovestheclinicalcourseofexperimentalautoimmunearthritis
AT silvesterponist hyperbilirubinemiamaintainedbychronicsupplementationofunconjugatedbilirubinimprovestheclinicalcourseofexperimentalautoimmunearthritis
AT monikadvorakova hyperbilirubinemiamaintainedbychronicsupplementationofunconjugatedbilirubinimprovestheclinicalcourseofexperimentalautoimmunearthritis
AT pavoljanega hyperbilirubinemiamaintainedbychronicsupplementationofunconjugatedbilirubinimprovestheclinicalcourseofexperimentalautoimmunearthritis
AT katarinabauerova hyperbilirubinemiamaintainedbychronicsupplementationofunconjugatedbilirubinimprovestheclinicalcourseofexperimentalautoimmunearthritis